ERBB2 and breast carcinoma: Similarly, a 2013 study by De Los Santos et al. found that the MRI accuracy in predicting pCR was 74%, with the highest rates reported among triple-negative breast cancer (37%) and HER2-positive breast cancer (38%) [7].